These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32603732)

  • 1. Biosensors for detection of Tau protein as an Alzheimer's disease marker.
    Ameri M; Shabaninejad Z; Movahedpour A; Sahebkar A; Mohammadi S; Hosseindoost S; Ebrahimi MS; Savardashtaki A; Karimipour M; Mirzaei H
    Int J Biol Macromol; 2020 Nov; 162():1100-1108. PubMed ID: 32603732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased cerebrospinal fluid tau in patients with Alzheimer's disease.
    Jensen M; Basun H; Lannfelt L
    Neurosci Lett; 1995 Feb; 186(2-3):189-91. PubMed ID: 7777193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Quantitative Profiling of Tau and Phosphorylated Tau Peptides in Cerebrospinal Fluid by Mass Spectrometry Provides New Biomarker Candidates.
    Russell CL; Mitra V; Hansson K; Blennow K; Gobom J; Zetterberg H; Hiltunen M; Ward M; Pike I
    J Alzheimers Dis; 2017; 55(1):303-313. PubMed ID: 27636850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer's disease.
    Cicognola C; Brinkmalm G; Wahlgren J; Portelius E; Gobom J; Cullen NC; Hansson O; Parnetti L; Constantinescu R; Wildsmith K; Chen HH; Beach TG; Lashley T; Zetterberg H; Blennow K; Höglund K
    Acta Neuropathol; 2019 Feb; 137(2):279-296. PubMed ID: 30547227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasensitive tau biosensor cells detect no seeding in Alzheimer's disease CSF.
    Hitt BD; Vaquer-Alicea J; Manon VA; Beaver JD; Kashmer OM; Garcia JN; Diamond MI
    Acta Neuropathol Commun; 2021 May; 9(1):99. PubMed ID: 34039426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer's disease.
    Ishiguro K; Ohno H; Arai H; Yamaguchi H; Urakami K; Park JM; Sato K; Kohno H; Imahori K
    Neurosci Lett; 1999 Jul; 270(2):91-4. PubMed ID: 10462105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's Disease-Associated Cerebrospinal Fluid (CSF) Biomarkers do not Correlate with CSF Volumes or CSF Production Rate.
    Edsbagge M; Andreasson U; Ambarki K; Wikkelsø C; Eklund A; Blennow K; Zetterberg H; Tullberg M
    J Alzheimers Dis; 2017; 58(3):821-828. PubMed ID: 28505972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.
    Tapiola T; Alafuzoff I; Herukka SK; Parkkinen L; Hartikainen P; Soininen H; Pirttilä T
    Arch Neurol; 2009 Mar; 66(3):382-9. PubMed ID: 19273758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid levels of A beta 42 and tau: potential markers of Alzheimer's disease.
    Galasko D
    J Neural Transm Suppl; 1998; 53():209-21. PubMed ID: 9700659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Cerebrospinal Fluid S100B Protein with Core Biomarkers and Cognitive Deficits in Prodromal and Mild Alzheimer's Disease.
    Christl J; Verhülsdonk S; Pessanha F; Menge T; Seitz RJ; Kujovic M; Höft B; Supprian T; Lange-Asschenfeldt C
    J Alzheimers Dis; 2019; 72(4):1119-1127. PubMed ID: 31683478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a prototype tau Thr231 phosphorylation CSF ELISA as a potential biomarker for Alzheimer's disease.
    Santos JRF; Bauer C; Schuchhardt J; Wedekind D; Waniek K; Lachmann I; Wiltfang J; Vogelgsang J
    J Neural Transm (Vienna); 2019 Mar; 126(3):339-348. PubMed ID: 30767082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid multiplexed detection of beta-amyloid and total-tau as biomarkers for Alzheimer's disease in cerebrospinal fluid.
    Song C; Deng P; Que L
    Nanomedicine; 2018 Aug; 14(6):1845-1852. PubMed ID: 29857195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Core biological marker candidates of Alzheimer's disease - perspectives for diagnosis, prediction of outcome and reflection of biological activity.
    Hampel H; Mitchell A; Blennow K; Frank RA; Brettschneider S; Weller L; Möller HJ
    J Neural Transm (Vienna); 2004 Mar; 111(3):247-72. PubMed ID: 14991453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers of Alzheimer's disease: the present and the future.
    Lehmann S; Delaby C; Touchon J; Hirtz C; Gabelle A
    Rev Neurol (Paris); 2013 Oct; 169(10):719-23. PubMed ID: 24021316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid biomarkers for Alzheimer's disease: current limitations and recent developments.
    Zetterberg H
    Curr Opin Psychiatry; 2015 Sep; 28(5):402-9. PubMed ID: 26147615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperphosphorylated tau protein in the cerebrospinal fluid of patients with Alzheimer's disease and other dementias: preliminary findings.
    Hartmann AP; Almeida SM; Livramento JA; Nitrini R; Takahashi D; Caramelli P
    Arq Neuropsiquiatr; 2004 Sep; 62(3B):751-5. PubMed ID: 15476062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined assessment of tau and neuronal thread protein in Alzheimer's disease CSF.
    Kahle PJ; Jakowec M; Teipel SJ; Hampel H; Petzinger GM; Di Monte DA; Silverberg GD; Möller HJ; Yesavage JA; Tinklenberg JR; Shooter EM; Murphy GM
    Neurology; 2000 Apr; 54(7):1498-504. PubMed ID: 10751266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF markers for Alzheimer's disease: total tau, phospho-tau and Abeta42.
    Andreasen N; Sjögren M; Blennow K
    World J Biol Psychiatry; 2003 Oct; 4(4):147-55. PubMed ID: 14608585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers.
    Ramos de Matos M; Ferreira C; Herukka SK; Soininen H; Janeiro A; Santana I; Baldeiras I; Almeida MR; Lleó A; Dols-Icardo O; Alcolea D; Benussi L; Binetti G; Paterlini A; Ghidoni R; Nacmias B; Meulenbroek O; van Waalwijk van Doorn LJC; Kuiperi HBJ; Hausner L; Waldemar G; Simonsen AH; Tsolaki M; Gkatzima O; Resende de Oliveira C; Verbeek MM; Clarimon J; Hiltunen M; de Mendonça A; Martins M
    J Alzheimers Dis; 2018; 66(2):639-652. PubMed ID: 30320580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer's disease.
    Tapiola T; Overmyer M; Lehtovirta M; Helisalmi S; Ramberg J; Alafuzoff I; Riekkinen P; Soininen H
    Neuroreport; 1997 Dec; 8(18):3961-3. PubMed ID: 9462474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.